DSD-C121
5α-reductase deficiency · 46,XY · DSD-C121
46,XY DSD (SRD type III / Prader-like classification) caused by 5α-reductase type 2 deficiency (SRD5A2 defect).
Images · 4
Case fields and evidence
- Category
-
5α-reductase deficiency
- Age
-
3 days (initial) → 14.5 months (post-treatment) → 2 years (first surgery) → 4.5 years (second surgery) → 6 years (most recent follow-up)
- Sex
-
Predominantly female phenotype at birth; the father had the name changed to a male name in the household registry; raised as male
- Karyotype
-
46,XY
- Genetics
-
AR, SRD5A2
- Phenotypes
-
Micropenis (HP:0000054); Hypospadias (HP:0000047)
- Diagnosis
-
46,XY DSD (SRD type III / Prader-like classification) caused by 5α-reductase type 2 deficiency (SRD5A2 defect).
- Follow-up
-
Follow-up at 6 years: height dropped to 55th percentile, bone age still ~1 year advanced, growth velocity −1.2 SDS; pubic hair clearly visible; never had UTI; family satisfied with surgical result.
- General phenotype
-
Predominantly female phenotype with ambiguous genitalia; increased shoulder hair; transient acceleration of bone age after treatment (side effect of testosterone).
- Imaging
-
Ultrasound: no internal female genitalia; voiding cystourethrogram: urogenital sinus + distal vaginal blind end
- Laboratory findings
-
T (pre-hCG): 0.75 ng/ml (time point: 8 days old, pre-hCG stimulation); T (post-hCG): 2.09 ng/ml (reference: normal response; time point: 72 h after hCG stimulation at 8 days); DHT (stimulated): 0.22 ng/ml (time point: 8 days); T/DHT ratio (stimulated): 9.5 (reference: <18 considered normal at the time, misleading; time point: 8 days); T (10 mo): 3.56 ng/ml (time point: recheck at 10 months); DHT (10 mo): 0.28 ng/ml (time point: 10 months); T/DHT ratio (10 mo): 12.7 (time point: 10 months); AR gene analysis: no abnormality; SRD5A2 gene: homozygous Leu55Gln (c.T164A) mutation in exon 1 (reference: both parents heterozygous carriers; time point: diagnosis); Karyotype: 46,XY normal
- Management
-
From 3 months: IM testosterone 50 mg q3w ×4 → switched to topical DHT ointment bid–tid → penis grew to 3.5 cm; first virilizing surgery at 2 years; second surgery at 3.5 years (resection of vaginal remnant + hypospadias repair); accelerated bone age is a known side effect.
- Pathology
-
Not reported (no gonadal biopsy performed)
- Genetic variants
-
c.T164A
- Evidence level
-
See source
- Clinical history
-
See source
- Perinatal history
-
See source
- Family history
-
See source
- Growth and development
-
See source
- External genital examination
-
See source
- Puberty / Tanner
-
See source
- Limitations
-
See source
Cite this resource
DSD Research Library | 5α-reductase deficiency · 46,XY · DSD-C121 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C121?version=v1.4.0